KCNQ1 is the human gene responsible in most cases for the long QT syndrome,
a genetic disorder characterized by anomalies in cardiac repolarization le
ading to arrhythmias and sudden death. KCNQ1 encodes a pore-forming K+ chan
nel subunit termed KvLQT1 which, in association with its regulatory beta -s
ubunit IsK (also called minK), produces the slow component of the delayed-r
ectifier cardiac K+ current. We used in situ hybridization to localize KvLQ
T1 and IsK mRNAs in various tissues from adult mice. We showed that KvLQT1
mRNA expression is widely distributed in epithelial tissues, in the absence
(small intestine, lung, liver, thymus) or presence (kidney, stomach, exocr
ine pancreas) of its regulator IsK. In the kidney and the stomach, however,
the expression patterns of KvLQT1 and IsK do not coincide. In many tissues
, in situ data obtained with the IsK probe coincide with beta -galactosidas
e expression in IsK-deficient mice in which the bacterial lacZ gene has bee
n substituted for the IsK coding region. Because expression of KvLQT1 in th
e presence or absence of its regulator generates a K+ current with differen
t biophysical characteristics, the role of KvLQT1 in epithelial cells may v
ary depending on the expression of its regulator IsK. The high level of KvL
QT1 expression in epithelial tissues is consistent with its potential role
in K+ secretion and recycling, in maintaining the resting potential, and in
regulating Cl- secretion and/or Na+ absorption.